Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as a selective NaV1.8 pain signal inhibitor, an alternative to opiates.
RFK Jr’s proposal to remove fluoride from tap water is a matter for debate. But his plan to improve school lunches is laudable, says Devi…
Satellite video calls will be coming to Europe from later this year, following a successful demo of the tech by Vodafone in partnership with AST…
Don’t like making calls or simply don’t have the time? Let Google call and ask questions for you. Here’s how.
Join us in for the 26th annual Las Vegas Dermatology seminar for the latest advancements in psoriasis, acne management and treatment, rosacea, cutaneous malignancies, and…
In a clinic in Guinea, a community health worker is puzzled by the number of people in a village becoming severely ill and reports this…
The surge of AI solutions flooding the market, including the recent launch of Deepstack, has drawn the attention of organizations worldwide.
Human hippocampal CA3 networks use sparse and broad synaptic connectivity, and their recurrent synapses employ reliability, precision, and long integration times to enhance memory capacity.…
Ramakrishnan et al. deleted AMPK in a spontaneous breast cancer metastasis mouse model and metastatic cell lines and showed that it is required for breast cancer…
The new 24B-parameter LLM ‘excels in scenarios where quick, accurate responses are critical.’ In fact, the model can be run on a MacBook with 32GB…
NYBC, one of the largest nonprofit blood centers in the country, said it does ‘not have a specific timetable for system restoration’ yet.
